HCPCS Level II code G0123 covers automated thin-layer screening cytopathology of cervical or vaginal specimens collected in preservative fluid, with initial review by a cytotechnologist under physician supervision. This code represents a common preventive screening service in women's health and pathology laboratories and is important nationally for cervical cancer screening programs and quality measurement in cytology services. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and laboratory workflow for this screening procedure, typical sites of service, and commonly applied billing modifiers. The publication summarizes reimbursement benchmark considerations, payer coverage trends, and coding practice points relevant to laboratories, pathology groups, and outpatient providers. The content also highlights areas where policy updates or payer-specific guidelines may affect billing and documentation. Data not available in the input for payer-specific rates, taxonomies, related codes, and ICD-10 mapping are noted as unavailable.